ONCO3.SA SAO
OncoclÃnicas do Brasil Serviços Médicos S.A.
1W: -3.8%
1M: -15.8%
3M: -10.6%
YTD: -60.1%
1Y: -77.0%
3Y: -91.6%
R$1.00 ($0.19)
-0.01 (-0.99%)
Weekly Expected Move ±16.3%
R$1
R$1
R$1
R$1
R$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$185M
-258.5% ▼
Capital Expenditures
$214M
+31.3% ▲
5Y CAGR: +2.4%
Free Cash Flow
-$399M
-9.9% ▼
Dividends Paid
$12M
+80.5% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$40K
-100.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$158M | -$22M | $114M | $224M | -$717M |
| Depreciation & Amort. | $107M | $127M | $175M | $257M | $326M |
| Stock-Based Comp. | $122M | $69M | $11M | $47M | $28M |
| Change in Working Capital | -$28M | -$217M | -$513M | -$507M | -$625M |
| Other Non-Cash Items | $143M | $34M | -$58M | $139M | $804M |
| Operating Cash Flow | $186M | -$9M | -$272M | -$52M | -$185M |
| — Investing Activities — | |||||
| Capital Expenditures | -$205M | -$202M | -$300M | -$312M | -$214M |
| Acquisitions (Net) | -$87M | -$402M | -$836M | -$46M | -$372M |
| Investment Purchases | -$64M | -$1.4B | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $734M | $0 | $0 |
| Other Investing | $444K | $6M | -$7M | $586M | -$1.1B |
| Investing Cash Flow | -$355M | -$2.0B | -$409M | $228M | -$1.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | $665M | $669M | $691M | $1.0B | $761M |
| Stock Repurchased | -$100M | -$177M | -$78M | -$34M | $0 |
| Dividends Paid | -$45M | -$26M | -$18M | -$60M | -$12M |
| Other Financing | -$57M | -$421M | -$189M | -$1.0B | -$338M |
| Financing Cash Flow | $463M | $1.8B | $407M | $111M | $1.9B |
| Net Change in Cash | $294M | -$204M | -$274M | $287M | $40K |
| Cash End of Period | $741M | $537M | $263M | $551M | $551M |
| Free Cash Flow | -$19M | -$211M | -$572M | -$363M | -$399M |